Your browser doesn't support javascript.
loading
Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort.
Quijano-Roy, Susana; Haberlova, Jana; Castiglioni, Claudia; Vissing, John; Munell, Francina; Rivier, François; Stojkovic, Tanya; Malfatti, Edoardo; Gómez García de la Banda, Marta; Tasca, Giorgio; Costa Comellas, Laura; Benezit, Audrey; Amthor, Helge; Dabaj, Ivana; Gontijo Camelo, Clara; Laforêt, Pascal; Rendu, John; Romero, Norma B; Cavassa, Eliana; Fattori, Fabiana; Beroud, Christophe; Zídková, Jana; Leboucq, Nicolas; Løkken, Nicoline; Sanchez-Montañez, Ángel; Ortega, Ximena; Kyncl, Martin; Metay, Corinne; Gómez-Andrés, David; Carlier, Robert Y.
Affiliation
  • Quijano-Roy S; APHP, GH Université Paris-Saclay, Neuromuscular Center, Child Neurology and ICU Department, Raymond Poincare Hospital, Garches, France.
  • Haberlova J; Université de Versailles, U1179 INSERM-UVSQ, Versailles, France.
  • Castiglioni C; Department of Paediatric Neurology, Motol University Hospital, Prague, Czech Republic.
  • Vissing J; Pediatric Neurology Department, Clinica Las Condes, Santiago de Chile, Chile.
  • Munell F; Instituto Nacional de Rehabilitación Pedro Aguirre Cerda, Santiago de Chile, Chile.
  • Rivier F; Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Stojkovic T; Pediatric Neurology, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain, Passeig de la Vall d'Hebron 119-129, 08035.
  • Malfatti E; Department of Pediatric Neurology and Reference Center for Neuromuscular Diseases AOC, CHU Montpellier, Montpellier, France.
  • Gómez García de la Banda M; PhyMedExp, University of Montpellier, INSERM, CNRS, Montpellier, France.
  • Tasca G; APHP, Neuromuscular Reference Center, Pitié-Salpêtrière Hospital, Institute of Myology, Paris, France.
  • Costa Comellas L; Univ Paris Est UPE, INSERM, U955 IMRB, APHP, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Hôpital Henri Mondor, Créteil, France.
  • Benezit A; APHP, GH Université Paris-Saclay, Neuromuscular Center, Child Neurology and ICU Department, Raymond Poincare Hospital, Garches, France.
  • Amthor H; Unità Operativa Complessa Di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia.
  • Dabaj I; Pediatric Neurology, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain, Passeig de la Vall d'Hebron 119-129, 08035.
  • Gontijo Camelo C; APHP, GH Université Paris-Saclay, Neuromuscular Center, Child Neurology and ICU Department, Raymond Poincare Hospital, Garches, France.
  • Laforêt P; APHP, GH Université Paris-Saclay, Neuromuscular Center, Child Neurology and ICU Department, Raymond Poincare Hospital, Garches, France.
  • Rendu J; Université de Versailles, U1179 INSERM-UVSQ, Versailles, France.
  • Romero NB; APHP, GH Université Paris-Saclay, Neuromuscular Center, Child Neurology and ICU Department, Raymond Poincare Hospital, Garches, France.
  • Cavassa E; CHU de Rouen, Service de Néonatologie, Réanimation pédiatrique, Neuropédiatrie et Éducation Fonctionnelle de L'enfant, INSERM U 1245, ED497, 76000, Rouen, France.
  • Fattori F; Department of Neurology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
  • Beroud C; Nord/Est/Ile de France Neuromuscular Reference Center, PHENIX FHU, Hôpital Raymond-Poincaré, AP-HP. INSERM U1179, Garches, France.
  • Zídková J; Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, GIN, Grenoble, France.
  • Leboucq N; Sorbonne Université, Myology Institute, Neuromuscular Morphology Unit, Center for Research in Myology, GH Pitié-Salpêtrière, Paris, France.
  • Løkken N; Centre de Référence de Pathologie Neuromusculaire Paris-Est, GHU Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Sanchez-Montañez Á; APHP, GH Université Paris-Saclay, Neuromuscular Center, Child Neurology and ICU Department, Raymond Poincare Hospital, Garches, France.
  • Ortega X; Unit for Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, Rome, Italy.
  • Kyncl M; APHM, Laboratoire de Génétique Moléculaire, Hôpital TIMONE Enfants; Aix Marseille University, INSERM, MMG, Marseille, France.
  • Metay C; Centre of Molecular Biology and Genetics, University Hospital Brno, Brno, Czech Republic.
  • Gómez-Andrés D; Radiology Department, CHU Montpellier, Montpellier, France.
  • Carlier RY; Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
J Neurol ; 269(5): 2414-2429, 2022 May.
Article in En | MEDLINE | ID: mdl-34559299
BACKGROUND: LAMA2-related muscular dystrophy (LAMA2-RD) encompasses a group of recessive muscular dystrophies caused by mutations in the LAMA2 gene, which codes for the alpha-2 chain of laminin-211 (merosin). Diagnosis is straightforward in the classic congenital presentation with no ambulation and complete merosin deficiency in muscle biopsy, but is far more difficult in milder ambulant individuals with partial merosin deficiency. OBJECTIVE: To investigate the diagnostic utility of muscle imaging in LAMA2-RD using whole-body magnetic resonance imaging (WBMRI). RESULTS: 27 patients (2-62 years, 21-80% with acquisition of walking ability and 6 never ambulant) were included in an international collaborative study. All carried two pathogenic mutations, mostly private missense changes. An intronic variant (c.909 + 7A > G) was identified in all the Chilean cases. Three patients (two ambulant) showed intellectual disability, epilepsy, and brain structural abnormalities. WBMRI T1w sequences or T2 fat-saturated images (Dixon) revealed abnormal muscle fat replacement predominantly in subscapularis, lumbar paraspinals, gluteus minimus and medius, posterior thigh (adductor magnus, biceps femoris, hamstrings) and soleus. This involvement pattern was consistent for both ambulant and non-ambulant patients. The degree of replacement was predominantly correlated to the disease duration, rather than to the onset or the clinical severity. A "COL6-like sandwich sign" was observed in several muscles in ambulant adults, but different involvement of subscapularis, gluteus minimus, and medius changes allowed distinguishing LAMA2-RD from collagenopathies. The thigh muscles seem to be the best ones to assess disease progression. CONCLUSION: WBMRI in LAMA2-RD shows a homogeneous pattern of brain and muscle imaging, representing a supportive diagnostic tool.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Magnetic Resonance Imaging / Muscular Dystrophies Type of study: Diagnostic_studies Limits: Adult / Humans Language: En Journal: J Neurol Year: 2022 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Magnetic Resonance Imaging / Muscular Dystrophies Type of study: Diagnostic_studies Limits: Adult / Humans Language: En Journal: J Neurol Year: 2022 Type: Article Affiliation country: France